METHOD FOR TREATING GLIOMAE AGGRAVATED WITH EPILEPTIC SYNDROME
medicine. SUBSTANCE: method involves per os administering riboxin to a patient at a dose of 0.2 g 3 times a day after removing tumor during 5-10 days. Radiation therapy is started at the same time with chemotherapy and brought to total dose of 42-54 Gr on the background of intravenous administration...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | KORYTOVA L.I ZHABINA R.M SOKURENKO V.P VARTANJAN L.P |
| description | medicine. SUBSTANCE: method involves per os administering riboxin to a patient at a dose of 0.2 g 3 times a day after removing tumor during 5-10 days. Radiation therapy is started at the same time with chemotherapy and brought to total dose of 42-54 Gr on the background of intravenous administration and later on per os administration of riboxin and proxiphein. Riboxin is intravenously injected at a dose of 10 ml during the first two weeks and then per os at a dose of 0.2 g three times a day up to 3 months long. Proxiphein is administered according to the following scheme. 2 days the dose is 0.25 g once a day, two days 0.25 g twice a day, and then, the dose is 0.25 g three times a day during 40-45 days. Chemotherapy course is repeated 4-5 weeks later. Benzonal is applied as anticonvulsive preparation at a dose of 0.1 g or finlepsin at a dose of 0.2 g 3 times a day during the first two weeks and then two times a day to the end of the chemotherapy course and later at a dose of 1 tablet before going to bed not less than 2-3 years long. EFFECT: enhanced effectiveness of treatment. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_RU2166948C1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>RU2166948C1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_RU2166948C13</originalsourceid><addsrcrecordid>eNrjZLDzdQ3x8HdRcPMPUggJcnUM8fRzV3D38fT3dXRVcHR3D3IMcwxxdVEI9wzxUHAN8PRxDQjxdFYIjvRzCfL3deVhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfFBoUaGZmaWJhbOhsZEKAEAEUAqAw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>METHOD FOR TREATING GLIOMAE AGGRAVATED WITH EPILEPTIC SYNDROME</title><source>esp@cenet</source><creator>KORYTOVA L.I ; ZHABINA R.M ; SOKURENKO V.P ; VARTANJAN L.P</creator><creatorcontrib>KORYTOVA L.I ; ZHABINA R.M ; SOKURENKO V.P ; VARTANJAN L.P</creatorcontrib><description>medicine. SUBSTANCE: method involves per os administering riboxin to a patient at a dose of 0.2 g 3 times a day after removing tumor during 5-10 days. Radiation therapy is started at the same time with chemotherapy and brought to total dose of 42-54 Gr on the background of intravenous administration and later on per os administration of riboxin and proxiphein. Riboxin is intravenously injected at a dose of 10 ml during the first two weeks and then per os at a dose of 0.2 g three times a day up to 3 months long. Proxiphein is administered according to the following scheme. 2 days the dose is 0.25 g once a day, two days 0.25 g twice a day, and then, the dose is 0.25 g three times a day during 40-45 days. Chemotherapy course is repeated 4-5 weeks later. Benzonal is applied as anticonvulsive preparation at a dose of 0.1 g or finlepsin at a dose of 0.2 g 3 times a day during the first two weeks and then two times a day to the end of the chemotherapy course and later at a dose of 1 tablet before going to bed not less than 2-3 years long. EFFECT: enhanced effectiveness of treatment.</description><edition>7</edition><language>eng</language><subject>ELECTROTHERAPY ; HUMAN NECESSITIES ; HYGIENE ; MAGNETOTHERAPY ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; RADIATION THERAPY ; ULTRASOUND THERAPY</subject><creationdate>2001</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20010520&DB=EPODOC&CC=RU&NR=2166948C1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20010520&DB=EPODOC&CC=RU&NR=2166948C1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>KORYTOVA L.I</creatorcontrib><creatorcontrib>ZHABINA R.M</creatorcontrib><creatorcontrib>SOKURENKO V.P</creatorcontrib><creatorcontrib>VARTANJAN L.P</creatorcontrib><title>METHOD FOR TREATING GLIOMAE AGGRAVATED WITH EPILEPTIC SYNDROME</title><description>medicine. SUBSTANCE: method involves per os administering riboxin to a patient at a dose of 0.2 g 3 times a day after removing tumor during 5-10 days. Radiation therapy is started at the same time with chemotherapy and brought to total dose of 42-54 Gr on the background of intravenous administration and later on per os administration of riboxin and proxiphein. Riboxin is intravenously injected at a dose of 10 ml during the first two weeks and then per os at a dose of 0.2 g three times a day up to 3 months long. Proxiphein is administered according to the following scheme. 2 days the dose is 0.25 g once a day, two days 0.25 g twice a day, and then, the dose is 0.25 g three times a day during 40-45 days. Chemotherapy course is repeated 4-5 weeks later. Benzonal is applied as anticonvulsive preparation at a dose of 0.1 g or finlepsin at a dose of 0.2 g 3 times a day during the first two weeks and then two times a day to the end of the chemotherapy course and later at a dose of 1 tablet before going to bed not less than 2-3 years long. EFFECT: enhanced effectiveness of treatment.</description><subject>ELECTROTHERAPY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MAGNETOTHERAPY</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>RADIATION THERAPY</subject><subject>ULTRASOUND THERAPY</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2001</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLDzdQ3x8HdRcPMPUggJcnUM8fRzV3D38fT3dXRVcHR3D3IMcwxxdVEI9wzxUHAN8PRxDQjxdFYIjvRzCfL3deVhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfFBoUaGZmaWJhbOhsZEKAEAEUAqAw</recordid><startdate>20010520</startdate><enddate>20010520</enddate><creator>KORYTOVA L.I</creator><creator>ZHABINA R.M</creator><creator>SOKURENKO V.P</creator><creator>VARTANJAN L.P</creator><scope>EVB</scope></search><sort><creationdate>20010520</creationdate><title>METHOD FOR TREATING GLIOMAE AGGRAVATED WITH EPILEPTIC SYNDROME</title><author>KORYTOVA L.I ; ZHABINA R.M ; SOKURENKO V.P ; VARTANJAN L.P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_RU2166948C13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2001</creationdate><topic>ELECTROTHERAPY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MAGNETOTHERAPY</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>RADIATION THERAPY</topic><topic>ULTRASOUND THERAPY</topic><toplevel>online_resources</toplevel><creatorcontrib>KORYTOVA L.I</creatorcontrib><creatorcontrib>ZHABINA R.M</creatorcontrib><creatorcontrib>SOKURENKO V.P</creatorcontrib><creatorcontrib>VARTANJAN L.P</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>KORYTOVA L.I</au><au>ZHABINA R.M</au><au>SOKURENKO V.P</au><au>VARTANJAN L.P</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>METHOD FOR TREATING GLIOMAE AGGRAVATED WITH EPILEPTIC SYNDROME</title><date>2001-05-20</date><risdate>2001</risdate><abstract>medicine. SUBSTANCE: method involves per os administering riboxin to a patient at a dose of 0.2 g 3 times a day after removing tumor during 5-10 days. Radiation therapy is started at the same time with chemotherapy and brought to total dose of 42-54 Gr on the background of intravenous administration and later on per os administration of riboxin and proxiphein. Riboxin is intravenously injected at a dose of 10 ml during the first two weeks and then per os at a dose of 0.2 g three times a day up to 3 months long. Proxiphein is administered according to the following scheme. 2 days the dose is 0.25 g once a day, two days 0.25 g twice a day, and then, the dose is 0.25 g three times a day during 40-45 days. Chemotherapy course is repeated 4-5 weeks later. Benzonal is applied as anticonvulsive preparation at a dose of 0.1 g or finlepsin at a dose of 0.2 g 3 times a day during the first two weeks and then two times a day to the end of the chemotherapy course and later at a dose of 1 tablet before going to bed not less than 2-3 years long. EFFECT: enhanced effectiveness of treatment.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_RU2166948C1 |
| source | esp@cenet |
| subjects | ELECTROTHERAPY HUMAN NECESSITIES HYGIENE MAGNETOTHERAPY MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES RADIATION THERAPY ULTRASOUND THERAPY |
| title | METHOD FOR TREATING GLIOMAE AGGRAVATED WITH EPILEPTIC SYNDROME |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T22%3A09%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=KORYTOVA%20L.I&rft.date=2001-05-20&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ERU2166948C1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |